Previous Close | 13.25 |
Open | 13.26 |
Bid | 12.79 x 800 |
Ask | 13.17 x 900 |
Day's Range | 12.79 - 13.38 |
52 Week Range | 12.06 - 41.50 |
Volume | |
Avg. Volume | 815,963 |
Market Cap | 635.553M |
Beta (5Y Monthly) | 1.09 |
PE Ratio (TTM) | 75.65 |
EPS (TTM) | 0.17 |
Earnings Date | May 01, 2024 - May 06, 2024 |
Forward Dividend & Yield | 0.24 (1.87%) |
Ex-Dividend Date | Feb 23, 2024 |
1y Target Est | 15.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for NUS
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nu Skin (NUS) is battling macroeconomic challenges, with inflation putting pressure on consumer spending and customer acquisition. Management expects revenues to decline in 2024.
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*